Public Contracts Scotland · Contract

CA02825 Ixekizumab (Taltz®)

A public procurement published by Aberdeenshire Council via Public Contracts Scotland.

Public Contracts ScotlandContract
Award value
Tender value
1
Suppliers
1
Awards
1
Notices
Contract
Stage

Overview

Supply of ixekizumab for new patients treated in NHS Scotland

Key details

Source
Public Contracts Scotland
Lifecycle stage
Contract
Status
complete
CPV classification
33600000
Currency
GBP
Total award value
Tender value
First published
30 Apr 2025
Last updated
30 Apr 2025
View the original notice

Awards

1 award recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
Belac Group LimitedSC367154

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Award,contractCA02825 Ixekizumab (Taltz®)

All suppliers

Frameworks & programmes

More from Aberdeenshire Council

FAQs about this procurement

Who is the buyer for "CA02825 Ixekizumab (Taltz®)"?

CA02825 Ixekizumab (Taltz®) is a UK public-sector procurement published by Aberdeenshire Council via Public Contracts Scotland.

Has "CA02825 Ixekizumab (Taltz®)" been awarded?

Yes — 1 award is recorded. The current lifecycle stage is "Contract".

Which suppliers are involved in "CA02825 Ixekizumab (Taltz®)"?

1 supplier is linked: Belac Group Limited.

When was "CA02825 Ixekizumab (Taltz®)" published?

It was first published on 30 Apr 2025 and last updated on 30 Apr 2025, across 1 notice.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable